Ipswich Investment Management Co., Inc. Guardant Health, Inc. Transaction History

Ipswich Investment Management Co., Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	SELL	$48.25 - $100.49 $724,618 - $1.51 Million	-15,018 Closed	0 $0
Q4 2021 Jan 24, 2022	SELL	$88.71 - $120.43 $71,855 - $97,548	-810 Reduced 5.12%	15,018 $1.5 Million
Q3 2021 Oct 07, 2021	BUY	$98.77 - $132.17 $17,778 - $23,790	180 Added 1.15%	15,828 $1.98 Million
Q2 2021 Aug 05, 2021	BUY	$109.77 - $165.68 $67,728 - $102,224	617 Added 4.1%	15,648 $1.94 Million
Q1 2021 Apr 09, 2021	SELL	$127.04 - $179.1 $7,495 - $10,566	-59 Reduced 0.39%	15,031 $2.29 Million
Q4 2020 Feb 05, 2021	BUY	$99.96 - $135.93 $52,479 - $71,363	525 Added 3.6%	15,090 $1.95 Million
Q3 2020 Oct 06, 2020	BUY	$80.32 - $111.8 $25,300 - $35,217	315 Added 2.21%	14,565 $1.63 Million
Q2 2020 Jul 09, 2020	BUY	$60.49 - $97.5 $7,863 - $12,675	130 Added 0.92%	14,250 $1.16 Million
Q1 2020 Apr 09, 2020	SELL	$59.04 - $88.81 $94,464 - $142,096	-1,600 Reduced 10.18%	14,120 $983,000
Q4 2019 Jan 08, 2020	SELL	$59.49 - $82.78 $88,640 - $123,342	-1,490 Reduced 8.66%	15,720 $1.23 Million
Q2 2019 Jul 11, 2019	BUY	$63.94 - $91.11 $1.1 Million - $1.57 Million	17,210 New	17,210 $1.49 Million

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Ipswich Investment Management Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Ipswich Investment Management Co., Inc. with notifications on news.